TABLE 4.
Vaccination status | Challenge dose (CFU) | Survival (no. of survivors/no. tested) |
---|---|---|
None | 2 × 102 | 0/9 |
None | 2 × 103 | 0/4 |
LVS | 2 × 102 | 8/9 |
LVS | 2 × 103 | 7/9 |
BALB/c mice were vaccinated i.n. with 200 CFU of LVS and 3 weeks later were challenged s.c. with 2 × 102 or 2 × 103 CFU of NMFTA1. The results show survival ratios on day 30 postchallenge, and all deaths occurred 5 to 6 days after challenge.